Spots Global Cancer Trial Database for unresectable pancreatic carcinoma

Every month we try and update this database with for unresectable pancreatic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer	NCT04158635	Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Bosentan Gemcitabine Nab-paclitaxel Quality-of-Life... Questionnaire A...	18 Years -	City of Hope Medical Center
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors and Lymphomas	NCT05053971	Advanced Lympho... Advanced Malign... Advanced Pancre... B-Cell Non-Hodg... Metastatic Panc... Refractory B-Ce... Refractory Lymp... Refractory Mali... Refractory Panc... Refractory T-Ce... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	BET Bromodomain... Core Biopsy Entinostat	18 Years -	National Cancer Institute (NCI)
Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas	NCT03925428	Advanced Lympho... Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Refractory B-Ce... Refractory Lymp... Refractory Mali... Refractory Panc... Refractory T-Ce... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Entinostat Molibresib	12 Years -	National Cancer Institute (NCI)
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer	NCT04673448	Anatomic Stage ... Anatomic Stage ... BRCA-Associated... BRCA-Associated... Metastatic BRCA... Metastatic Brea... Metastatic Fall... Metastatic Mali... Metastatic Ovar... Metastatic Panc... Metastatic Prim... Prognostic Stag... Prognostic Stag... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Br... Unresectable Fa... Unresectable Ma... Unresectable Ov... Unresectable Pa... Unresectable Pr...	Dostarlimab Niraparib	18 Years -	University of Washington
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery	NCT02896907	Pancreatic Aden... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Oxaliplatin Irinotecan Hydr... Leucovorin Calc... Fluorouracil Ascorbic Acid	18 Years - 75 Years	Thomas Jefferson University
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer	NCT03825289	Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Hydroxychloroqu... Trametinib	18 Years -	University of Utah
Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer	NCT03819088	Gastric Carcino... Liver and Intra... Unresectable Es... Unresectable Pa...	Zinc	-	Emory University
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery	NCT02336087	Pancreatic Aden... Unresectable Pa... Stage III Pancr... Stage IV Pancre...	Gemcitabine Hyd... Paclitaxel Albu... Metformin Hydro... Therapeutic Die... Laboratory Biom... Quality-of-Life...	18 Years -	City of Hope Medical Center
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer	NCT03257761	Extrahepatic Bi... Gallbladder Ade... Metastatic Panc... Recurrent Chola... Recurrent Gallb... Recurrent Hepat... Recurrent Intra... Recurrent Pancr... Stage III Gallb... Stage III Hepat... Stage III Intra... Stage III Pancr... Stage IIIA Gall... Stage IIIA Hepa... Stage IIIB Gall... Stage IIIB Hepa... Stage IIIC Hepa... Stage IV Gallbl... Stage IV Hepato... Stage IV Pancre... Stage IVA Gallb... Stage IVA Hepat... Stage IVA Intra... Stage IVB Gallb... Stage IVB Hepat... Stage IVB Intra... Unresectable Ga... Unresectable Pa...	Durvalumab Guadecitabine	18 Years -	University of Southern California
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery	NCT02194829	Metastatic Panc... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	AZD1775 Gemcitabine Nab-paclitaxel	18 Years -	National Cancer Institute (NCI)
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors	NCT02498613	Advanced Malign... Metastatic Lung... Metastatic Lung... Metastatic Panc... Metastatic Trip... Pancreatic Duct... Stage III Breas... Stage III Lung ... Stage III Lung ... Stage III Pancr... Stage IIIA Brea... Stage IIIA Lung... Stage IIIA Lung... Stage IIIB Brea... Stage IIIB Lung... Stage IIIB Lung... Stage IIIC Brea... Stage IV Breast... Stage IV Lung N... Stage IV Lung S... Stage IV Pancre... Triple-Negative... Unresectable Lu... Unresectable Pa... Unresectable Pa... Unresectable Tr...	18F-Fluoromison... Cediranib Malea... Laboratory Biom... Olaparib Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer	NCT03825289	Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Hydroxychloroqu... Trametinib	18 Years -	University of Utah
Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients	NCT02767557	Unresectable Pa...	Tocilizumab Gemcitabine nab-Paclitaxel	18 Years -	Herlev Hospital
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University
Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery	NCT01783171	Pancreatic Aden... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Akt Inhibitor M... Dinaciclib Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors	NCT02498613	Advanced Malign... Metastatic Lung... Metastatic Lung... Metastatic Panc... Metastatic Trip... Pancreatic Duct... Stage III Breas... Stage III Lung ... Stage III Lung ... Stage III Pancr... Stage IIIA Brea... Stage IIIA Lung... Stage IIIA Lung... Stage IIIB Brea... Stage IIIB Lung... Stage IIIB Lung... Stage IIIC Brea... Stage IV Breast... Stage IV Lung N... Stage IV Lung S... Stage IV Pancre... Triple-Negative... Unresectable Lu... Unresectable Pa... Unresectable Pa... Unresectable Tr...	18F-Fluoromison... Cediranib Malea... Laboratory Biom... Olaparib Positron Emissi...	18 Years -	National Cancer Institute (NCI)
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	NCT02595931	Metastatic Colo... Metastatic Lung... Metastatic Mali... Metastatic Panc... Refractory Colo... Refractory Lung... Refractory Mali... Refractory Panc... Stage III Color... Stage III Lung ... Stage III Pancr... Stage IV Colore... Stage IV Lung C... Stage IV Pancre... Unresectable Co... Unresectable Lu... Unresectable Ma... Unresectable Pa...	Berzosertib Biopsy Specimen Biospecimen Col... Computed Tomogr... Irinotecan Hydr...	18 Years -	National Cancer Institute (NCI)
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study	NCT03033225	Advanced Pancre... Locally Advance... Metastatic Panc... Pancreatic Neop... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Endoscopic Ultr... Fluorescence Im... Photodynamic Th... Quality-of-Life... Questionnaire A... Verteporfin	18 Years -	Mayo Clinic
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer	NCT05411094	Locally Advance... Stage II Pancre... Stage III Pancr... Unresectable Pa...	Biopsy Biospecimen Col... Diagnostic Imag... Durvalumab Olaparib Radiation Thera...	18 Years -	National Cancer Institute (NCI)
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery	NCT02194829	Metastatic Panc... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	AZD1775 Gemcitabine Nab-paclitaxel	18 Years -	National Cancer Institute (NCI)
Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas	NCT03925428	Advanced Lympho... Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Refractory B-Ce... Refractory Lymp... Refractory Mali... Refractory Panc... Refractory T-Ce... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Entinostat Molibresib	12 Years -	National Cancer Institute (NCI)
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer	NCT03095781	Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa...	XL888 Pembrolizumab	18 Years -	Emory University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: